Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$368M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$298M |
| 4 |
Delta Air Lines
DAL
|
+$208M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 2 |
Tesla
TSLA
|
+$353M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$290M |
| 5 |
Boeing
BA
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.27% |
| 2 | Healthcare | 18.47% |
| 3 | Consumer Discretionary | 12.34% |
| 4 | Consumer Staples | 10.13% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SLNO
1926
DELISTED
Soleno Therapeutics
SLNO
| $1.82M | ﹤0.01% |
61,554
-4,500
| -7% | -$27.2K |
|
1927
Grupo Aval
AVAL
$6.07B
| $1.81M | ﹤0.01% |
750,172
-72,081
| -9% | -$176K |
|
1928
Republic Bancorp
RBCAA
$1.96B
| $1.81M | ﹤0.01% |
41,100
+6,000
| +17% | +$267K |
|
1929
iShares S&P 500 Growth ETF
IVW
$77B
| $1.81M | ﹤0.01% |
26,400
+18,000
| +214% | +$1.27M |
|
|
FOLD
1930
DELISTED
Amicus Therapeutics
FOLD
| $1.8M | ﹤0.01% |
+148,400
| New | +$1.91M |
|
1931
Castle Biosciences
CSTL
$931M
| $1.8M | ﹤0.01% |
106,800
-65,600
| -38% | -$1.15M |
|
1932
Ceco Environmental
CECO
$4.01B
| $1.78M | ﹤0.01% |
111,783
-24,400
| -18% | -$334K |
|
|
PHLT
1933
DELISTED
Performant Healthcare Inc
PHLT
| $1.78M | ﹤0.01% |
789,063
-54,400
| -6% | -$138K |
|
1934
Standard BioTools
LAB
$313M
| $1.78M | ﹤0.01% |
613,400
-11,909
| -2% | -$31.1K |
|
1935
Astec Industries
ASTE
$1.02B
| $1.77M | ﹤0.01% |
37,645
+32,200
| +591% | +$1.59M |
|
1936
WisdomTree International Hedged Quality Dividend Growth Fund
IHDG
$2.24B
| $1.77M | ﹤0.01% |
45,700
+3,800
| +9% | +$150K |
|
|
PLGO
1937
Pelagos Insurance Capital
PLGO
$2.18B
| $1.76M | ﹤0.01% |
+120,000
| New | +$1.68M |
|
|
SAGE
1938
DELISTED
Sage Therapeutics
SAGE
| $1.76M | ﹤0.01% |
+85,600
| New | +$2.47M |
|
1939
Virco
VIRC
$95.2M
| $1.76M | ﹤0.01% |
221,630
+8,266
| +4% | +$39.6K |
|
1940
Envista
NVST
$4.46B
| $1.76M | ﹤0.01% |
+63,000
| New | +$2.04M |
|
1941
Schwab Fundamental US Large Company Index ETF
FNDX
$27.2B
| $1.75M | ﹤0.01% |
93,900
-1,800
| -2% | -$34.8K |
|
1942
Newmont
NEM
$111B
| $1.75M | ﹤0.01% |
47,300
-2,100
| -4% | -$85.4K |
|
1943
Bar Harbor Bankshares
BHB
$673M
| $1.75M | ﹤0.01% |
73,984
-2,700
| -4% | -$68K |
|
|
SRT
1944
DELISTED
Startek Inc.
SRT
| $1.75M | ﹤0.01% |
537,400
-6,100
| -1% | -$19K |
|
1945
PepsiCo
PEP
$189B
| $1.74M | ﹤0.01% |
10,259
-794,913
| -99% | -$144M |
|
|
EBIX
1946
DELISTED
Ebix Inc
EBIX
| $1.74M | ﹤0.01% |
+175,687
| New | +$3.42M |
|
|
EH
1947
EHang Holdings
EH
$404M
| $1.73M | ﹤0.01% |
+96,200
| New | +$1.77M |
|
|
AZUL
1948
DELISTED
Azul
AZUL
| $1.73M | ﹤0.01% |
+201,400
| New | +$2M |
|
1949
Fulgent Genetics
FLGT
$510M
| $1.73M | ﹤0.01% |
64,700
-32,254
| -33% | -$1.1M |
|
1950
Aquestive Therapeutics
AQST
$492M
| $1.73M | ﹤0.01% |
1,129,189
-101,007
| -8% | -$174K |
|
Similar funds
Renaissance Technologies's Q3 2023 Portfolio in Review
As of Q3 2023, Renaissance Technologies held 4,329 positions worth $58.7B, down 15% from $69.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $8.34B in Q3 2023, closing 713 positions and reducing 1,794 holdings. Its most notable exit was Chevron, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in D.R. Horton worth $125M.
- Renaissance Technologies's largest Q3 2023 buy was D.R. Horton: 1,159,438 shares worth $125M.
- Renaissance Technologies added most to Netflix in Q3 2023, an estimated $385M increase.
- Renaissance Technologies's biggest Q3 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.34B.
- Renaissance Technologies fully exited Chevron in Q3 2023, selling an estimated $185M.
- Renaissance Technologies's ten largest holdings make up 12% of its $58.7B portfolio in Q3 2023.
- Renaissance Technologies opened 464 new positions and closed 713 in Q3 2023.
- Renaissance Technologies's portfolio value fell 15% quarter-over-quarter to $58.7B.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.